Literature DB >> 7426327

Cytolysis of fibroblasts by C3a.

A Temple, A C Allison.   

Abstract

C3a was found to be more cytolytic to transformed than to primary fibroblast cultures from mouse and man. Fibroblasts made quiescent with caffeine were lysed by the same concentrations of C3a as untreated cells. These findings may have implications in tumour immunity.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7426327      PMCID： PMC2010458          DOI： 10.1038/bjc.1980.198

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  15 in total

1.  Selective killing of transformed baby hamster kidney (BHK) cells.

Authors:  A B Pardee; L J James
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

2.  Ability of activated complement components to induce lysosomal enzyme release from macrophages.

Authors:  H U Schorlemmer; P Davies; A C Allison
Journal:  Nature       Date:  1976-05-06       Impact factor: 49.962

3.  Interaction of C3b, B, and D in the alternative pathway of complement activation.

Authors:  A Nicholson; V Brade; H U Schorlemmer; R Burger; D Bitter-Suermann; U Hadding
Journal:  J Immunol       Date:  1975-10       Impact factor: 5.422

4.  Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5.

Authors:  D Bitter-Suermann; U Hadding; F Melchert; H J Wellensiek
Journal:  Immunochemistry       Date:  1970-12

5.  In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man.

Authors:  R F Lai A Fat; R van Furth
Journal:  Immunology       Date:  1975-02       Impact factor: 7.397

6.  Cutaneous responses to human C 3 anaphylatoxin in man.

Authors:  K D Wuepper; V A Bokisch; H J Müller-Eberhard; R B Stoughton
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

7.  Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase.

Authors:  V A Bokisch; H J Müller-Eberhard
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

Review 8.  Trans-membrane control of the receptors on normal and tumor cells. II. Surface changes associated with transformation and malignancy.

Authors:  G L Nicolson
Journal:  Biochim Biophys Acta       Date:  1976-04-30

9.  Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.

Authors:  W D da Silva; J W Eisele; I H Lepow
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

10.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.